Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
Anesth Analg ; 129(3): 762-773, 2019 09.
Artigo em Inglês | MEDLINE | ID: mdl-31425218

RESUMO

Despite over a half-century of recognizing fibrinolytic abnormalities after trauma, we remain in our infancy in understanding the underlying mechanisms causing these changes, resulting in ineffective treatment strategies. With the increased utilization of viscoelastic hemostatic assays (VHAs) to measure fibrinolysis in trauma, more questions than answers are emerging. Although it seems certain that low fibrinolytic activity measured by VHA is common after injury and associated with increased mortality, we now recognize subphenotypes within this population and that specific cohorts arise depending on the specific time from injury when samples are collected. Future studies should focus on these subtleties and distinctions, as hypofibrinolysis, acute shutdown, and persistent shutdown appear to represent distinct, unique clinical phenotypes, with different pathophysiology, and warranting different treatment strategies.


Assuntos
Fibrinólise/fisiologia , Escala de Gravidade do Ferimento , Ferimentos e Lesões/diagnóstico , Ferimentos e Lesões/terapia , Transtornos da Coagulação Sanguínea/diagnóstico , Transtornos da Coagulação Sanguínea/terapia , Ensaios Clínicos como Assunto/métodos , Humanos , Tromboelastografia/métodos
2.
Injury ; 46(5): 807-13, 2015 May.
Artigo em Inglês | MEDLINE | ID: mdl-25682314

RESUMO

INTRODUCTION: Early recognition and treatment of trauma patients requiring massive transfusion (MT) has been shown to reduce mortality. While many risk factors predicting MT have been demonstrated, there is no universally accepted method or algorithm to identify these patients. We hypothesised that even among experienced trauma surgeons, the clinical gestalt of identifying patients who will require MT is unreliable. METHODS: Transfusion and mortality outcomes after trauma were observed at 10 U.S. Level-1 trauma centres in patients who survived ≥ 30 min after admission and received ≥ 1 unit of RBC within 6h of arrival. Subjects who received ≥ 10 units within 24h of admission were classified as MT patients. Trauma surgeons were asked the clinical gestalt question "Is the patient likely to be massively transfused?" 10 min after the patients arrival. The performance of clinical gestalt to predict MT was assessed using chi-square tests and ROC analysis to compare gestalt to previously described scoring systems. RESULTS: Of the 1245 patients enrolled, 966 met inclusion criteria and 221 (23%) patients received MT. 415 (43%) were predicted to have a MT and 551(57%) were predicted to not have MT. Patients predicted to have MT were younger, more often sustained penetrating trauma, had higher ISS scores, higher heart rates, and lower systolic blood pressures (all p<0.05). Gestalt sensitivity was 65.6% and specificity was 63.8%. PPV and NPV were 34.9% and 86.2% respectively. CONCLUSION: Data from this large multicenter trial demonstrates that predicting the need for MT continues to be a challenge. Because of the increased mortality associated with delayed therapy, a more reliable algorithm is needed to identify and treat these severely injured patients earlier.


Assuntos
Transfusão de Sangue/estatística & dados numéricos , Exsanguinação/terapia , Centros de Traumatologia/organização & administração , Ferimentos e Lesões/terapia , Adulto , Transfusão de Sangue/mortalidade , Exsanguinação/mortalidade , Feminino , Teoria Gestáltica , Humanos , Masculino , Pessoa de Meia-Idade , Valor Preditivo dos Testes , Estudos Prospectivos , Reprodutibilidade dos Testes , Medição de Risco , Índice de Gravidade de Doença , Fatores de Tempo , Ferimentos e Lesões/complicações , Ferimentos e Lesões/mortalidade
3.
Emerg Infect Dis ; 8(10): 1019-28, 2002 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-12396909

RESUMO

In October 2001, the first inhalational anthrax case in the United States since 1976 was identified in a media company worker in Florida. A national investigation was initiated to identify additional cases and determine possible exposures to Bacillus anthracis. Surveillance was enhanced through health-care facilities, laboratories, and other means to identify cases, which were defined as clinically compatible illness with laboratory-confirmed B. anthracis infection. From October 4 to November 20, 2001, 22 cases of anthrax (11 inhalational, 11 cutaneous) were identified; 5 of the inhalational cases were fatal. Twenty (91%) case-patients were either mail handlers or were exposed to worksites where contaminated mail was processed or received. B. anthracis isolates from four powder-containing envelopes, 17 specimens from patients, and 106 environmental samples were indistinguishable by molecular subtyping. Illness and death occurred not only at targeted worksites, but also along the path of mail and in other settings. Continued vigilance for cases is needed among health-care providers and members of the public health and law enforcement communities.


Assuntos
Antraz/epidemiologia , Bacillus anthracis/isolamento & purificação , Bioterrorismo/estatística & dados numéricos , Adulto , Idoso , Antraz/tratamento farmacológico , Antraz/mortalidade , Antraz/prevenção & controle , Antibioticoprofilaxia , Centers for Disease Control and Prevention, U.S. , Surtos de Doenças , Exposição Ambiental , Monitoramento Ambiental , Monitoramento Epidemiológico , Feminino , Humanos , Lactente , Exposição por Inalação , Masculino , Pessoa de Meia-Idade , Exposição Ocupacional , Serviços Postais , Pós , Saúde Pública , Infecções Respiratórias/tratamento farmacológico , Infecções Respiratórias/epidemiologia , Infecções Respiratórias/mortalidade , Infecções Respiratórias/prevenção & controle , Dermatopatias Bacterianas/tratamento farmacológico , Dermatopatias Bacterianas/epidemiologia , Dermatopatias Bacterianas/microbiologia , Dermatopatias Bacterianas/prevenção & controle , Esporos Bacterianos/isolamento & purificação , Estados Unidos/epidemiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA